Get the Stockscreener App
10.26
0.14%
-0.0146
Drugs Made In America Acquisition Corp stock is traded at $10.26, with a volume of 50,978.
It is down -0.14% in the last 24 hours and down -0.14% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.27
Open:
$10.24
24h Volume:
50,978
Relative Volume:
1.17
Market Cap:
$343.73M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.04%
1M Performance:
-0.14%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.23
$10.28
1-Week Range:
$10.22
$10.28
52-Week Range:
$9.96
$10.28
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
954-870-3104
Address
2 PELICAN DR., FORT LAUDERDALE
Compare DMAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.26 | 344.56M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.15 | 1.82B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
AACT
Ares Acquisition Corporation Ii
|
11.40 | 704.58M | 0 | 16.92M | -1.35M | 0.29 |
|
AAM
Aa Mission Acquisition Corp
|
10.47 | 460.19M | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
10.12 | 526.75M | 0 | 0 | 0 | 0.00 |
|
TACO
Berto Acquisition Corp
|
10.31 | 389.82M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Technical Bounce Expected in Drugs Made In America Acquisition Corp. Equity Right Next Week2025 Short Interest & Weekly High Return Stock Forecasts - mustnews.co.kr
How Drugs Made In America Acquisition Corp. Equity Right stock performs during market volatility - Newser
Long term hold vs stop loss in Drugs Made In America Acquisition Corp. Equity RightQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
How to build a custom watchlist for Drugs Made In America Acquisition Corp.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Applying big data sentiment scoring on Drugs Made In America Acquisition Corp. Equity RightJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Predicting Drugs Made In America Acquisition Corp. trend using moving averagesJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser
Price momentum metrics for FULTP explainedTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Is UNCY a candidate for recovery playIPO Watch & Free Growth Oriented Trading Recommendations - Newser
Drugs Made In America Acquisition Corp. Equity Right stock outlook for YEARSwing Trade & Community Verified Trade Signals - Newser
Predicting Drugs Made In America Acquisition Corp. Equity Right trend using moving averagesMarket Volume Summary & Low Risk Entry Point Guides - Newser
Momentum divergence signals in Drugs Made In America Acquisition Corp. Equity Right chart2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Is Drugs Made In America Acquisition Corp. Equity Right stock ready for a breakout2025 Technical Overview & Safe Entry Zone Identification - Newser
Is this a good reentry point in Sonic Automotive Inc.July 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
Can technical indicators confirm Drugs Made In America Acquisition Corp.’s reversalTrade Volume Report & Risk Controlled Daily Plans - Newser
Intraday pattern recognizer results for Drugs Made In America Acquisition Corp. Equity RightJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
What the charts say about CNEY todayBreakout Watch & Low Drawdown Momentum Ideas - Newser
Will Brillia Inc stock recover after recent dropJuly 2025 Decliners & Verified Momentum Stock Ideas - Newser
Using Python tools to backtest Drugs Made In America Acquisition Corp. Equity Right strategiesEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Will GP Act III Acquisition Corp. Equity Warrant outperform the marketWeekly Trade Review & Free Technical Confirmation Trade Alerts - Newser
PHX Minerals Inc. recovery potential after sell offTrade Volume Summary & Weekly High Momentum Picks - Newser
Analyzing COLL with multi timeframe chartsQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What momentum shifts mean for Drugs Made In America Acquisition Corp.Swing Trade & Reliable Volume Spike Alerts - Newser
Strategies to average down on Drugs Made In America Acquisition Corp. Equity RightEarnings Risk Summary & Growth Focused Stock Reports - Newser
Market reaction to SHEL’s recent newsMarket Sentiment Summary & Verified Technical Trade Signals - Newser
Published on: 2025-08-19 14:21:25 - Newser
Applying sector rotation models to Drugs Made In America Acquisition Corp.Market Activity Recap & Long-Term Growth Portfolio Plans - Newser
Will Dolby Laboratories Inc. price bounce be sustainableWatch List & Weekly Momentum Picks - Newser
What technical models suggest about BENF’s comebackInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Forecasting Drugs Made In America Acquisition Corp. Equity Right price range with options dataLayoff News & Weekly Top Stock Performers List - Newser
Using Ichimoku Cloud for LIMNW technicalsJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Can LINKBANCORP Inc. rally from current levelsBond Market & Long-Term Growth Plans - Newser
Published on: 2025-08-19 06:46:12 - Newser
Relative strength of Drugs Made In America Acquisition Corp. Equity Right in sector analysisQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Using RSI to spot recovery in Karat Packaging Inc.Quarterly Earnings Summary & Safe Entry Zone Identification - Newser
What to do if you’re stuck in Groupon Inc.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Historical volatility pattern of SANUWAVE Health Inc. visualizedStop Loss & Verified Momentum Stock Watchlist - Newser
Price momentum metrics for Drugs Made In America Acquisition Corp. Equity Right explained2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Real time scanner hits for Foot Locker Inc. explainedInsider Selling & Long-Term Capital Growth Ideas - Newser
Custom watchlist performance reports with Drugs Made In America Acquisition Corp.July 2025 Pullbacks & Daily Volume Surge Trade Alerts - Newser
Predicting Ecopetrol S.A. Depositary Receipt trend using moving averagesM&A Rumor & Verified Swing Trading Watchlists - Newser
Using flow based indicators on DSGRShare Buyback & AI Powered Market Entry Strategies - Newser
How to read the order book for UEICJuly 2025 Decliners & Community Consensus Picks - Newser
Reversal indicators forming on Drugs Made In America Acquisition Corp. stock2025 Sector Review & Consistent Profit Trading Strategies - Newser
Should you hold or exit Drugs Made In America Acquisition Corp. Equity Right now2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Exit strategy if you’re trapped in Best Buy Co. Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
Drugs Made In America Acquisition Corp. Equity Right stock trend forecastJuly 2025 Setups & AI Powered Market Entry Ideas - Newser
What technical models suggest about Gulfport Energy Corporation’s comebackWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
What earnings revisions data tells us about iHuman Inc. Depositary ReceiptJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Using economic indicators to assess Panacea Acquisition Corp. Equity Warrant potential2025 Performance Recap & Community Trade Idea Sharing - Newser
Momentum divergence signals in KAVL chartProfit Target & Consistent Profit Alerts - Newser
Using Python tools to backtest AENTW strategiesTrade Performance Summary & Smart Swing Trading Techniques - Newser
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):